ElkinsMR, ByePT. Mechanisms and applications of hypertonic saline. J R Soc Med, 2011; 104(Suppl 1):S2–S5.
2.
KellettF, RedfernJ, NivenRM. Evaluation of nebulised hypertonic saline (7%) as an adjunct to physiotherapy in patients with stable bronchiectasis. Respir Med, 2005; 99(1):27–31.
3.
BadgettRG, VindhyalM, StirnamanJT, GibsonCM, HalabyR. A Living systematic review of nebulized hypertonic saline for acute bronchiolitis in infants. JAMA Pediatr, 2015; 169(8):788–789.
4.
DilmenU, KaragolBS, OguzSS. Nebulized hypertonic saline and recombinant human DNase in the treatment of pulmonary atelectasis in newborns. Pediatr Int, 2011; 53(3):328–331.
5.
RobinsonM, HemmingAL, RegnisJA, WongAG, BaileyDL, BautovichGJ, et al. Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Thorax, 1997; 52(10):900–903.
6.
LiebermanJ, KurnickNB. Influence of deoxyribonucleic acid content on the proteolysis of sputum and pus. Nature, 1962; 196:988–990.
7.
DonaldsonSH, BennettWD, ZemanKL, KnowlesMR, TarranR, BoucherRC. Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Engl J Med, 2006; 354(3):241–250.
8.
RobinsonM, RegnisJA, BaileyDL, KingM, BautovichGJ, ByePT. Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis. Am J Respir Crit Care Med, 1996; 153(5):1503–1509.
9.
MurrayTS. The effect of hypertonic saline on in vitro Pseudomonas aeruginosa colonization. Pediatr Pulmol, 2010; 45:A367.
10.
GouldNS, GauthierS, KariyaCT, MinE, HuangJ, BrianDJ. Hypertonic saline increases lung epithelial lining fluid glutathione and thiocyanate: two protective CFTR-dependent thiols against oxidative injury. Respir Res, 2010; 11:119–120.
11.
WohlauerM, MooreEE, SillimanCC, FragosoM, GamboniF, HarrJ, et al. Nebulized hypertonic saline attenuates acute lung injury following trauma and hemorrhagic shock via inhibition of matrix metalloproteinase-13. Crit Care Med, 2012; 40(9):2647–2653.
12.
Flores-GonzálezJC, Matamala-MorilloMA, Rodríguez-CampoyP, Pérez-GuerreroJJ, Serrano-MoyanoB, Comino-VazquezP, et al. Epinephrine improves the efficacy of nebulized hypertonic saline in moderate bronchiolitis: a randomised clinical trial. PLoS One, 2015; 10(11):e0142847.
13.
RalstonS, HillV, MartinezM. Nebulized hypertonic saline without adjunctive bronchodilators for children with bronchiolitis. Pediatrics, 2010; 126(3):e520–e525.
14.
ClaudiusC, PernerA, MøllerMH. Nebulised dornase alfa versus placebo or hypertonic saline in adult critically ill patients: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis. Syst Rev, 2015; 4:153–154.
15.
SheinSL, GallagherJT, DeakinsKM, WeinertDM. Prophylactic use of nebulized hypertonic saline in mechanically ventilated children: a randomized blinded pilot study. Respir Care, 2016; 61(5):586–592.
16.
AriA, HarwoodRJ, SheardMM, FinkJB. An in vitro evaluation of aerosol delivery through tracheostomy and endotracheal tubes using different interfaces. Respir Care, 2012; 57(7):1066–1070.
17.
SchleufeP, ReiffenHP, PiepenbrockS. Effective application of bronchodilator aerosols from metered-dose inhalers (MDI) via resuscitator-bag and adapter. Resuscitation, 1998; 39(3):175–178.
18.
FlorinTA, ShawKN, KittickM, YakscoeS, ZorcJJ. Nebulized hypertonic saline for bronchiolitis in the emergency department: a randomized clinical trial. JAMA Pediatr, 2014; 168(7):664–670.
19.
PrincipiT, KomarL. A critical review of “a randomized trial of nebulized 3% hypertonic saline with epinephrine in the treatment of acute bronchiolitis in the emergency department.”. J Popul Ther Clin Pharmacol, 2011; 18(2):e273–e274.
